Terms: = Liver cancer AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A
4372 results:
1. Role of CENPF and NDC80 in the rehabilitation nursing of hepatocellular carcinoma and cirrhosis: An observational study.
Jia W; Wu Q; Li R; Hou S; Kang C
Medicine (Baltimore); 2024 May; 103(18):e37984. PubMed ID: 38701255
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive pan-cancer analysis of YBX family reveals YBX2 as a potential biomarker in liver cancer.
Yuan Z; Li B; Liao W; Kang D; Deng X; Tang H; Xie J; Hu D; Chen A
Front Immunol; 2024; 15():1382520. PubMed ID: 38698857
[TBL] [Abstract] [Full Text] [Related]
3. Progressive sarcopenia and myosteatosis predict prognosis of advanced HCC patients treated with immune checkpoint inhibitors.
Liu M; Jin Q; Wang H; Li Y
Front Immunol; 2024; 15():1396927. PubMed ID: 38690276
[TBL] [Abstract] [Full Text] [Related]
4. Autonomous circadian rhythms in the human hepatocyte regulate hepatic drug metabolism and inflammatory responses.
March S; Nerurkar N; Jain A; Andrus L; Kim D; Whittaker CA; Tan EKW; Thiberge S; Fleming HE; Mancio-Silva L; Rice CM; Bhatia SN
Sci Adv; 2024 Apr; 10(17):eadm9281. PubMed ID: 38657074
[TBL] [Abstract] [Full Text] [Related]
5. The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamics.
Sherman DJ; Liu L; Mamrosh JL; Xie J; Ferbas J; Lomenick B; Ladinsky MS; Verma R; Rulifson IC; Deshaies RJ
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2318619121. PubMed ID: 38657050
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy and safety of tislelizumab plus lenvatinib as first-line treatment in patients with unresectable hepatocellular carcinoma: a multicenter, single-arm, phase 2 trial.
Xu L; Chen J; Liu C; Song X; Zhang Y; Zhao H; Yan S; Jia W; Wu Z; Guo Y; Yang J; Gong W; Ma Y; Yang X; Gao Z; Zhang N; Zheng X; Li M; Su D; Chen M
BMC Med; 2024 Apr; 22(1):172. PubMed ID: 38650037
[TBL] [Abstract] [Full Text] [Related]
7. Single-cell analysis revealed a potential role of T-cell exhaustion in colorectal cancer with liver metastasis.
Ling T; Zhang C; Liu Y; Jiang C; Gu L
J Cell Mol Med; 2024 Apr; 28(8):e18341. PubMed ID: 38647235
[TBL] [Abstract] [Full Text] [Related]
8. [Research Progress of Cellular Lipid Droplets in Oral Diseases].
Xu S; Wei J; Xie J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2024 Mar; 55(2):475-481. PubMed ID: 38645850
[TBL] [Abstract] [Full Text] [Related]
9. Low-abundance proteins-based label-free SERS approach for high precision detection of liver cancer with different stages.
Sun T; Lin Y; Yu Y; Gao S; Gao X; Zhang H; Lin K; Lin J
Anal Chim Acta; 2024 May; 1304():342518. PubMed ID: 38637045
[TBL] [Abstract] [Full Text] [Related]
10. Predisposing deleterious variants in the cancer-associated human kinases in the global populations.
Khan SA; Anwar M; Gohar A; Roosan MR; Hoessli DC; Khatoon A; Shakeel M
PLoS One; 2024; 19(4):e0298747. PubMed ID: 38635549
[TBL] [Abstract] [Full Text] [Related]
11. Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment.
Liu L; Zhang M; Cui N; Liu W; Di G; Wang Y; Xi X; Li H; Shen Z; Gu M; Wang Z; Jiang S; Liu B
PLoS One; 2024; 19(4):e0298004. PubMed ID: 38635528
[TBL] [Abstract] [Full Text] [Related]
12. Tumor conspicuity enhancement-based segmentation model for liver tumor segmentation and RECIST diameter measurement in non-contrast CT images.
Liu H; Zhou Y; Gou S; Luo Z
Comput Biol Med; 2024 May; 174():108420. PubMed ID: 38613896
[TBL] [Abstract] [Full Text] [Related]
13. NXPH4 can be used as a biomarker for pan-cancer and promotes colon cancer progression.
Zhang Z; Wang P; Chen S; Xiang D; Chen J; Huang W; Liu X; Yi T; Wang D; Pu Y; He L; Zhang H
Aging (Albany NY); 2024 Apr; 16(7):5866-5886. PubMed ID: 38613793
[TBL] [Abstract] [Full Text] [Related]
14. Dynamic radiomics based on contrast-enhanced MRI for predicting microvascular invasion in hepatocellular carcinoma.
Zhang R; Wang Y; Li Z; Shi Y; Yu D; Huang Q; Chen F; Xiao W; Hong Y; Feng Z
BMC Med Imaging; 2024 Apr; 24(1):80. PubMed ID: 38584254
[TBL] [Abstract] [Full Text] [Related]
15. Proteomic analysis of DEN and CCl
Zhang Q; Liu Y; Ren L; Li J; Lin W; Lou L; Wang M; Li C; Jiang Y
Sci Rep; 2024 Apr; 14(1):8013. PubMed ID: 38580754
[TBL] [Abstract] [Full Text] [Related]
16. A prognostic signature established based on genes related to tumor microenvironment for patients with hepatocellular carcinoma.
Cui Z; Li G; Shi Y; Zhao X; Wang J; Hu S; Chen C; Li G
Aging (Albany NY); 2024 Apr; 16(7):6537-6549. PubMed ID: 38579170
[TBL] [Abstract] [Full Text] [Related]
17. Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing.
Zheng L; Wang Y; Liu Z; Wang Z; Tao C; Wu A; Li H; Xiao T; Li Z; Rong W
Cancer Med; 2024 Apr; 13(7):e7043. PubMed ID: 38572921
[TBL] [Abstract] [Full Text] [Related]
18. Developing risk models and subtypes of autophagy-associated LncRNAs for enhanced prognostic prediction and precision in therapeutic approaches for liver cancer patients.
Zhang LU; Chu J; Yu Y
Oncol Res; 2024; 32(4):703-716. PubMed ID: 38560571
[TBL] [Abstract] [Full Text] [Related]
19. The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy.
Lu W; Wu G; Miao X; Ma J; Wang Y; Xu H; Shentu D; Xue S; Xia Q; Wang Y; Wang L
Cancer Immunol Immunother; 2024 Mar; 73(5):87. PubMed ID: 38554161
[TBL] [Abstract] [Full Text] [Related]
20. Identification of diagnostic gene signatures and molecular mechanisms for non-alcoholic fatty liver disease and Alzheimer's disease through machine learning algorithms.
Jiang L; Wang Q; Jiang Y; Peng D; Zong K; Li S; Xie W; Zhang C; Li K; Wu Z; Huang Z
Clin Chim Acta; 2024 Apr; 557():117892. PubMed ID: 38537674
[TBL] [Abstract] [Full Text] [Related]
[Next]
